Characterization of tau oligomeric seeds in progressive supranuclear palsy.
about
Neuronal network disintegration: common pathways linking neurodegenerative diseasesTau Oligomers: The Toxic Player at Synapses in Alzheimer's DiseaseKey emerging issues in progressive supranuclear palsy and corticobasal degenerationCo-expression of truncated and full-length tau induces severe neurotoxicityPropagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.Roles of tau protein in health and disease.Phosphoregulation of Tau modulates inhibition of kinesin-1 motility.Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer's Disease and Related Tauopathies.Tau oligomers in cerebrospinal fluid in Alzheimer's disease.Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.Invited review: Drug development for tauopathies.The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration.Therapeutic Strategies for Restoring Tau Homeostasis.Signaling pathways and posttranslational modifications of tau in Alzheimer's disease: the humanization of yeast cells.Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases.Tau Oligomers as Pathogenic Seeds: Preparation and Propagation In Vitro and In Vivo.Tau-mediated Neurodegeneration and Potential Implications in Diagnosis and Treatment of Alzheimer's Disease.Production of recombinant tau oligomers in vitro.Clinical heterogeneity in progressive supranuclear palsy: challenges to diagnosis, pathogenesis and future therapies.Tau Oligomers Derived from Traumatic Brain Injury Cause Cognitive Impairment and Accelerate Onset of Pathology in Htau Mice.Prospects for strain-specific immunotherapy in Alzheimer's disease and tauopathies.Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies.Is it Useful to Classify PSP and CBD as Different Disorders? Yes
P2860
Q26750287-778270BC-E1DC-4848-88D3-51916593C68DQ26773154-61D82F81-77F2-43A7-9C69-069BB502D48CQ28084976-8F50D365-06FE-49F3-8E84-F967ADDBE9B5Q30829185-13000B0C-9DC7-4289-8DAE-D544FF925F80Q31024674-055E9D1B-3871-4EED-A6BB-D2F07AE103EDQ33559303-691F089D-9552-4E14-9206-5B6B33DDAD75Q33563366-B2679070-83C2-442A-A05B-D760ABF92014Q33714234-2C172FE6-41AB-4BCE-846A-1D4EC372ABCBQ37733987-746011E7-066F-4BBB-90C9-66BC18A43A58Q37736091-67619DF5-4931-4CED-83D9-FFD605E4BF36Q38263698-0142CCA6-F436-4C71-853E-D63D43FBF614Q38520167-76A2EDA8-5C02-4AFA-B987-5A2CD7842011Q39118898-A5046283-5D0E-456F-8928-39E48CBE6986Q39208164-37E92BC5-0696-4712-977C-B13D46C35013Q42355513-7C3FF5B8-73CA-400D-BEE5-49167EA1C93FQ46445872-0F8E2C04-434E-45A7-80CC-7AD9EDA0E830Q47296152-CCA24754-9950-4FD3-978A-60EAA31EA2F1Q47839739-F05EC1BE-BFAA-45B1-8A4F-9FE0A21F6798Q48717188-A36FADB4-301E-451E-8D34-EB3B93B50661Q49052601-916C5D8C-8316-4B5A-AB64-B78AE4317423Q50532471-B5316D23-148D-48DC-A358-16A914463C70Q52679169-FE63FA12-8631-405F-9486-B9BF23559C0AQ58575653-AB379269-8B48-4DFE-B0B3-65D53668B3F4
P2860
Characterization of tau oligomeric seeds in progressive supranuclear palsy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Characterization of tau oligomeric seeds in progressive supranuclear palsy.
@ast
Characterization of tau oligomeric seeds in progressive supranuclear palsy.
@en
Characterization of tau oligomeric seeds in progressive supranuclear palsy.
@nl
type
label
Characterization of tau oligomeric seeds in progressive supranuclear palsy.
@ast
Characterization of tau oligomeric seeds in progressive supranuclear palsy.
@en
Characterization of tau oligomeric seeds in progressive supranuclear palsy.
@nl
prefLabel
Characterization of tau oligomeric seeds in progressive supranuclear palsy.
@ast
Characterization of tau oligomeric seeds in progressive supranuclear palsy.
@en
Characterization of tau oligomeric seeds in progressive supranuclear palsy.
@nl
P2093
P2860
P356
P1476
Characterization of tau oligomeric seeds in progressive supranuclear palsy.
@en
P2093
Cristian A Lasagna-Reeves
Juan Troncoso
Julia E Gerson
Marcos J Guerrero-Muñoz
Rakez Kayed
Urmi Sengupta
P2860
P2888
P356
10.1186/2051-5960-2-73
P577
2014-06-14T00:00:00Z
P5875
P6179
1042244987